Table 1.

Summary of modeled scenarios according to baseline HbA1c, target HbA1c, delay in intensification, and time horizon

Baseline HbA1c,  % (mmol/mol)	Target HbA1c,  % (mmol/mol)	Immediate intensification versus	Time horizona
7.0 (53)	6.5 (48)	1-year delay 2-year delay 3-year delay 5-year delay 7-year delay	1 year 2 years 3 years 5 years 10 years 30 years
9.0 (75)	8.0 (64) 7.0 (53) 6.5 (48)	1-year delay 2-year delay 3-year delay 5-year delay 7-year delay	1 year 2 years 3 years 5 years 10 years 30 years
11.0 (97)	9.0 (75) 8.0 (64) 7.0 (53) 6.5 (48)	1-year delay 2-year delay 3-year delay 5-year delay 7-year delay	1 year 2 years 3 years 5 years 10 years 30 years
13.0 (119)	9.0 (75) 8.0 (64) 7.0 (53) 6.5 (48)	1-year delay 2-year delay 3-year delay 5-year delay 7-year delay	1 year 2 years 3 years 5 years 10 years 30 years
15.0 (140)	9.0 (75) 8.0 (64) 7.0 (53) 6.5 (48)	1-year delay 2-year delay 3-year delay 5-year delay 7-year delay	1 year 2 years 3 years 5 years 10 years 30 years

Modeled scenarios presented in the manuscript are in bold. See Supplementary Material for results for modeled scenarios not presented in the main text

HbA1c glycated hemoglobin

^aOnly simulations with time horizons equal to or longer than the delay of intensification were run